Microsoft selbst warnt vor der Verwendung von Internet Explorer, da er nicht mehr den neuesten Web- und Sicherheitsstandards entspricht. Wir können daher nicht garantieren, dass die Seite im Internet Explorer in vollem Umfang funktioniert. Nutze bitte Chrome oder Firefox.

Is Novavax's Biggest Catalyst Ever Just Ahead?

TheMotleyFool

0 0

Is Novavax's Biggest Catalyst Ever Just Ahead?Photo, wide shot, wide-angle lens, Clinical research organization, Blue hour, twilight, cool, ISO1200, slow shutter speed, photo by Michael Light: https://img.theapi.app/temp/c28f6640-54ba-4d2b-afbe-b5fd3b0ee19e.png

Novavax (NASDAQ: NVAX) has reported a string of good news since late last year. More than 35 countries have authorized its coronavirus vaccine

Novavax has shipped doses, and healthcare facilities around the world are administering them. The vaccine is showing efficacy against omicron and other variants. And the company predicts 2022 revenue in the range of $4 billion to $5 billion.

Yet the shares haven't joined in on the celebrations. Novavax stock has dropped more than 40% since the start of the year. At the same time, a catalyst may be only days away.

Source Fool.com

Like: 0

NVAX

Teilen